Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2013-09-26
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+1.68%+3.19%+3.55%+10.97% 50.44B
+0.72%+1.00%+396.18%+624.25% 40.63B
+2.54%+0.93%+28.98%-3.62% 34.88B
+0.31%+1.74%+18.44%+59.76% 33.67B
-2.09%-1.98%+3.21%+33.56% 26.29B
-0.63%+0.34% - - 17.11B
+0.66%-3.96%+66.85%+127.36% 15.29B
-23.90%-21.43%+50.06%+53.83% 10.62B
+2.59%-0.49%+15.24%+21.25% 13.74B
Average -1.69%-2.71%+72.81%+115.92% 26.96B
Weighted average by Cap. -0.25%-0.61%+87.59%+139.64%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock